STOCKS TO TRADE IN COMING DAYS

 

As expected market remained volatile throughout the day. Fluctuating between losses and gains before finally ending the day flat.Today Sensex rose 95 points to 38067 while the Nifty retested 11300 levels only to reverse the gains to end the day 25 points higher at 11247. The volatility will continue due to the surge in coronavirus infections, US elections and geopolitical reasons. Some bit of volatility and consolidation can happen. However, structurally, we may see decent liquidity for a good period of time. At times like these, buying on decline is be a better strategy with a defensive portfolio positioning.

SEVEN HEALTHY STOCKS 👇
HEROMOTOCORP- This stock is in a sweet spot as strong rural-led recovery plays to its strength in the economy and executive category in the motorcycles segment. We believe Hero MotoCorp has multiple re-rating triggers, including the return of volume growth, a possible foothold in premium motorcycles, scooters and exports.

HCL TECNOLOGY-  HCL Tech given its robust business model, high return ratios, strong management team, and a reasonable valuation. We expect HCL Tech to better navigate the current crisis and emerge stronger due to an expected increase in enterprise demand for digital services. Our confidence partly stems from the company’s historical track record of adapting to multiple business challenges and technology change cycles.

BHARTIAIRTEL- The sharp correction of 25 % over the last month offers a strong risk-reward from current levels and would scale to all-time high levels over the next few years.

HDFC- This stock increasing credit by the bank's subsidiary provides an opportunity for further penetration of the client base and stable margins to deliver consistent growth in earnings and valuations.

ICICIBANK- ICICI Bank is well-positioned to deliver strong business momentum with advances growth of 17%, a consistent margin of 3% & better asset quality to aid return ratios.The stock trades at 1.8 times FY22E adjusted book value below the long-term average and price correction of 30% is providing comfort at the current levels.

UPL- UPL remains well-positioned for long-term growth given its strong market position, diverse product offering, expectations of reduced debt levels and decent revenue and cost synergies from Arysta acquisition.

FOR SUCH LIVE MARKET TIPS PLEASE FILL UP THIS FORM👉👉👉👉👉